Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience

BACKGROUND/AIM: To assess the real-life efficacy, retention rate, and safety data of tofacitinib in rheumatoid arthritis (RA) patients. MATERIALS AND METHODS: We analyzed all patients registered in the HURBİO database who received at least 1 dose of tofacitinib. Patients who received at least one do...

Descripción completa

Detalles Bibliográficos
Autores principales: BİLGİN, Emre, CEYLAN, Furkan, DURAN, Emine, FARİSOĞULLARI, Bayram, BÖLEK, Ertuğrul Çağrı, YARDIMCI, Gözde Kübra, KILIÇ, Levent, AKDOĞAN, Ali, KARADAĞ, Ömer, BİLGEN, Şule Apraş, KİRAZ, Sedat, ERTENLİ, Ali İhsan, KALYONCU, Umut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991862/
https://www.ncbi.nlm.nih.gov/pubmed/32979899
http://dx.doi.org/10.3906/sag-2007-123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991862/
https://www.ncbi.nlm.nih.gov/pubmed/32979899
http://dx.doi.org/10.3906/sag-2007-123

Ejemplares similares